News and events

Youth-Onset Type 2 Diabetes (Y-T2D) is increasingly recognized as a critical public health challenge, with patients facing accelerated cardiovascular risks at an early age. A groundbreaking study published in Circulation Research explores the role of small extracellular vesicles (sEVs) derived from plasma in mediating endothelial dysfunction and their correlation with subclinical coronary atherosclerosis in Y-T2D patients as shown in the image abstract.

A recent study published in PLoS Pathogens explores the effectiveness of alpaca-derived nanobodies against the SARS-CoV-2 Omicron variant. With the Omicron variant’s numerous mutations rendering traditional antibody-based therapies less effective, nanobody technology emerges as a promising alternative.

How can researchers unlock the potential of plant-based extracellular vesicles (EVs) in cancer therapy? A recent review published in Materials Advances highlights the transformative potential of plant-derived EVs in cancer therapy. These nanoscale vesicles, naturally produced by plants, offer a sustainable and effective approach to delivering anti-cancer drugs while minimizing side effects.